Adam's practice focuses primarily on mergers, acquisitions, divestitures, equity financings, joint ventures and exit strategies. Adam also counsels clients on corporate reorganizations and general corporate governance matters. Adam advises clients across a number of different industries, including healthcare, life sciences, manufacturing, financial services, technology and others.
Prior to joining Eversheds Sutherland, Adam practiced at a global law firm in Chicago, where he represented private equity clients and private and public companies in a variety of transactions, as well as general corporate governance matters.
Latest News
- client newsEversheds Sutherland Advises Azurity Pharmaceuticals on Expansion of Portfolio with CONTRAVE® and Related Assets
- firm newsEversheds Sutherland Announces Promotions of US Partners and Counsel for 2026
- client newsEversheds Sutherland advises Azurity Pharmaceuticals on Acquisition of Sebela’s Bowel Prep Franchise
client news
July 06, 2026
Eversheds Sutherland Advises Azurity Pharmaceuticals on Expansion of Portfo...
firm news
December 02, 2025
Eversheds Sutherland Announces Promotions of US Partners and Counsel for 20...
client news
November 24, 2025
Eversheds Sutherland advises Azurity Pharmaceuticals on Acquisition of Sebe...
- Named to the “Ones to Watch” list by Best Lawyers in the area of corporate law (2026) and Mergers and Acquisitions (2026)
- Georgia
- Illinois
- J.D., Emory University School of Law
- M.B.A., Xavier University, magna cum laude
- B.S., Xavier University